• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Crystal Structure of Calmodulin Bound to the Cardiac Ryanodine Receptor (RyR2) at Residues Phe4246-Val4271 Reveals a Fifth Calcium Binding Site.钙调蛋白与心脏兰尼碱受体(RyR2)结合的晶体结构(残基 Phe4246-Val4271)揭示了第五个钙结合位点。
Biochemistry. 2021 Apr 13;60(14):1088-1096. doi: 10.1021/acs.biochem.1c00152. Epub 2021 Mar 23.
2
Ca-dependent calmodulin binding to cardiac ryanodine receptor (RyR2) calmodulin-binding domains.钙依赖的钙调蛋白与心脏兰尼碱受体(RyR2)钙调蛋白结合域的结合。
Biochem J. 2019 Jan 18;476(2):193-209. doi: 10.1042/BCJ20180545.
3
Role of cardiac ryanodine receptor calmodulin-binding domains in mediating the action of arrhythmogenic calmodulin N-domain mutation N54I.心脏兰尼碱受体钙调蛋白结合域在介导致心律失常性钙调蛋白 N 端结构域突变 N54I 作用中的作用。
FEBS J. 2020 Jun;287(11):2256-2280. doi: 10.1111/febs.15147. Epub 2019 Dec 18.
4
Loss of S100A1 expression leads to Ca release potentiation in mutant mice with disrupted CaM and S100A1 binding to CaMBD2 of RyR1.S100A1表达缺失导致RyR1的CaM和S100A1与CaMBD2结合被破坏的突变小鼠中钙释放增强。
Physiol Rep. 2018 Aug;6(15):e13822. doi: 10.14814/phy2.13822.
5
The arrhythmogenic N53I variant subtly changes the structure and dynamics in the calmodulin N-terminal domain, altering its interaction with the cardiac ryanodine receptor.致心律失常的 N53I 变异体细微地改变了钙调蛋白 N 端结构域的结构和动力学,改变了其与心脏兰尼碱受体的相互作用。
J Biol Chem. 2020 May 29;295(22):7620-7634. doi: 10.1074/jbc.RA120.013430. Epub 2020 Apr 21.
6
Molecular basis of calmodulin binding to cardiac muscle Ca(2+) release channel (ryanodine receptor).钙调蛋白与心肌钙释放通道(兰尼碱受体)结合的分子基础。
J Biol Chem. 2003 Jun 27;278(26):23480-6. doi: 10.1074/jbc.M301125200. Epub 2003 Apr 21.
7
Arrhythmogenic Calmodulin Mutations Affect the Activation and Termination of Cardiac Ryanodine Receptor-mediated Ca2+ Release.致心律失常的钙调蛋白突变影响心脏雷诺丁受体介导的Ca2+释放的激活和终止。
J Biol Chem. 2015 Oct 23;290(43):26151-62. doi: 10.1074/jbc.M115.676627. Epub 2015 Aug 26.
8
Two EF-hand motifs in ryanodine receptor calcium release channels contribute to isoform-specific regulation by calmodulin.兰尼碱受体钙释放通道中的两个EF手型基序有助于钙调蛋白对亚型特异性的调节。
Cell Calcium. 2017 Sep;66:62-70. doi: 10.1016/j.ceca.2017.05.013. Epub 2017 Jun 6.
9
Life-threatening arrhythmogenic CaM mutations disrupt CaM binding to a distinct RyR2 CaM-binding pocket.危及生命的心律失常钙调蛋白突变会破坏钙调蛋白与 RyR2 钙调蛋白结合口袋的结合。
Biochim Biophys Acta Gen Subj. 2023 Apr;1867(4):130313. doi: 10.1016/j.bbagen.2023.130313. Epub 2023 Jan 21.
10
Diminished inhibition and facilitated activation of RyR2-mediated Ca release is a common defect of arrhythmogenic calmodulin mutations.RYR2 介导的钙释放抑制减弱和激活增强是致心律失常钙调蛋白突变的共同缺陷。
FEBS J. 2019 Nov;286(22):4554-4578. doi: 10.1111/febs.14969. Epub 2019 Jul 12.

引用本文的文献

1
Calmodulin binding is required for calcium mediated TRPA1 desensitization.钙调蛋白结合是钙介导的TRPA1脱敏所必需的。
bioRxiv. 2024 Dec 12:2024.12.11.627969. doi: 10.1101/2024.12.11.627969.
2
Arrhythmia-Associated Calmodulin E105A Mutation Alters the Binding Affinity of CaM to a Ryanodine Receptor 2 CaM-Binding Pocket.心律失常相关钙调蛋白 E105A 突变改变了钙调蛋白与 Ryanodine 受体 2 钙调蛋白结合口袋的结合亲和力。
Int J Mol Sci. 2023 Oct 26;24(21):15630. doi: 10.3390/ijms242115630.
3
Structural analyses of human ryanodine receptor type 2 channels reveal the mechanisms for sudden cardiac death and treatment.人2型兰尼碱受体通道的结构分析揭示了心脏性猝死及治疗的机制。
Sci Adv. 2022 Jul 22;8(29):eabo1272. doi: 10.1126/sciadv.abo1272. Epub 2022 Jul 20.
4
Physiologically Relevant Free Ca Ion Concentrations Regulate STRA6-Calmodulin Complex Formation via the BP2 Region of STRA6.生理相关的游离 Ca2+ 离子浓度通过 STRA6 的 BP2 区域调节 STRA6-钙调蛋白复合物的形成。
J Mol Biol. 2021 Nov 5;433(22):167272. doi: 10.1016/j.jmb.2021.167272. Epub 2021 Sep 27.

本文引用的文献

1
Pathological conformations of disease mutant Ryanodine Receptors revealed by cryo-EM.冷冻电镜揭示疾病突变兰尼碱受体的病理构象。
Nat Commun. 2021 Feb 5;12(1):807. doi: 10.1038/s41467-021-21141-3.
2
The arrhythmogenic N53I variant subtly changes the structure and dynamics in the calmodulin N-terminal domain, altering its interaction with the cardiac ryanodine receptor.致心律失常的 N53I 变异体细微地改变了钙调蛋白 N 端结构域的结构和动力学,改变了其与心脏兰尼碱受体的相互作用。
J Biol Chem. 2020 May 29;295(22):7620-7634. doi: 10.1074/jbc.RA120.013430. Epub 2020 Apr 21.
3
Calmodulin Mutations Associated with Heart Arrhythmia: A Status Report.钙调蛋白突变与心律失常:现状报告。
Int J Mol Sci. 2020 Feb 19;21(4):1418. doi: 10.3390/ijms21041418.
4
α-Actinin-1 promotes activity of the L-type Ca channel Ca 1.2.α-辅肌动蛋白-1 促进 L 型钙通道 Ca 1.2 的活性。
EMBO J. 2020 Mar 2;39(5):e102622. doi: 10.15252/embj.2019102622. Epub 2020 Jan 27.
5
Role of cardiac ryanodine receptor calmodulin-binding domains in mediating the action of arrhythmogenic calmodulin N-domain mutation N54I.心脏兰尼碱受体钙调蛋白结合域在介导致心律失常性钙调蛋白 N 端结构域突变 N54I 作用中的作用。
FEBS J. 2020 Jun;287(11):2256-2280. doi: 10.1111/febs.15147. Epub 2019 Dec 18.
6
Slaying a giant: Structures of calmodulin and protein kinase a bound to the cardiac ryanodine receptor.斩巨擘:钙调蛋白和蛋白激酶 A 与心脏兰尼碱受体结合的结构。
Cell Calcium. 2019 Nov;83:102079. doi: 10.1016/j.ceca.2019.102079. Epub 2019 Sep 6.
7
Modulation of cardiac ryanodine receptor 2 by calmodulin.钙调蛋白对心脏兰尼碱受体 2 的调节。
Nature. 2019 Aug;572(7769):347-351. doi: 10.1038/s41586-019-1377-y. Epub 2019 Jul 5.
8
Structural insight into TRPV5 channel function and modulation.TRPV5 通道功能和调节的结构见解。
Proc Natl Acad Sci U S A. 2019 Apr 30;116(18):8869-8878. doi: 10.1073/pnas.1820323116. Epub 2019 Apr 11.
9
Ca-dependent calmodulin binding to cardiac ryanodine receptor (RyR2) calmodulin-binding domains.钙依赖的钙调蛋白与心脏兰尼碱受体(RyR2)钙调蛋白结合域的结合。
Biochem J. 2019 Jan 18;476(2):193-209. doi: 10.1042/BCJ20180545.
10
Mechanism of calmodulin inactivation of the calcium-selective TRP channel TRPV6.钙调蛋白失活钙选择性 TRP 通道 TRPV6 的机制。
Sci Adv. 2018 Aug 15;4(8):eaau6088. doi: 10.1126/sciadv.aau6088. eCollection 2018 Aug.

钙调蛋白与心脏兰尼碱受体(RyR2)结合的晶体结构(残基 Phe4246-Val4271)揭示了第五个钙结合位点。

The Crystal Structure of Calmodulin Bound to the Cardiac Ryanodine Receptor (RyR2) at Residues Phe4246-Val4271 Reveals a Fifth Calcium Binding Site.

机构信息

Department of Chemistry, University of California, Davis, California 95616, United States.

Department of Molecular and Cellular Biology, University of California, Davis, California 95616, United States.

出版信息

Biochemistry. 2021 Apr 13;60(14):1088-1096. doi: 10.1021/acs.biochem.1c00152. Epub 2021 Mar 23.

DOI:10.1021/acs.biochem.1c00152
PMID:33754699
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8211408/
Abstract

Calmodulin (CaM) regulates the activity of a Ca channel known as the cardiac ryanodine receptor (RyR2), which facilitates the release of Ca from the sarcoplasmic reticulum during excitation-contraction coupling in cardiomyocytes. Mutations that disrupt this CaM-dependent channel inactivation result in cardiac arrhythmias. RyR2 contains three different CaM binding sites: CaMBD1 (residues 1940-1965), CaMBD2 (residues 3580-3611), and CaMBD3 (residues 4246-4275). Here, we report a crystal structure of Ca-bound CaM bound to RyR2 CaMBD3. The structure reveals Ca bound to the four EF-hands of CaM as well as a fifth Ca bound to CaM in the interdomain linker region involving Asp81 and Glu85. The CaM mutant E85A abolishes the binding of the fifth Ca and weakens the binding of CaMBD3 to Ca-bound CaM. Thus, the binding of the fifth Ca is important for stabilizing the complex in solution and is not a crystalline artifact. The CaMBD3 peptide in the complex adopts an α-helix (between Phe4246 and Val4271) that interacts with both lobes of CaM. Hydrophobic residues in the CaMBD3 helix (Leu4255 and Leu4259) form intermolecular contacts with the CaM N-lobe, and the CaMBD3 mutations (L4255A and L4259A) each weaken the binding of CaM to RyR2. Aromatic residues on the opposite side of the CaMBD3 helix (Phe4246 and Tyr4250) interact with the CaM C-lobe, but the mutants (F4246A and Y4250A) have no detectable effect on CaM binding in solution. We suggest that the binding of CaM to CaMBD3 and the binding of a fifth Ca to CaM may contribute to the regulation of RyR2 channel function.

摘要

钙调蛋白(CaM)调节一种称为心脏兰尼碱受体(RyR2)的 Ca 通道的活性,该通道在心肌细胞兴奋-收缩偶联过程中促进 Ca 从肌浆网释放。破坏这种 CaM 依赖性通道失活的突变会导致心律失常。RyR2 包含三个不同的 CaM 结合位点:CaMBD1(残基 1940-1965)、CaMBD2(残基 3580-3611)和 CaMBD3(残基 4246-4275)。在这里,我们报告了一个结合 Ca 的 CaM 与 RyR2 CaMBD3 结合的晶体结构。该结构揭示了 Ca 结合到 CaM 的四个 EF 手以及第五个 Ca 结合到包含 Asp81 和 Glu85 的 CaM 结构域连接区。CaM 突变体 E85A 消除了第五个 Ca 的结合并削弱了 CaMBD3 与 Ca 结合的 CaM 的结合。因此,第五个 Ca 的结合对于稳定溶液中的复合物很重要,而不是晶体假象。复合物中的 CaMBD3 肽采用 α-螺旋(位于 Phe4246 和 Val4271 之间),与 CaM 的两个叶相互作用。CaMBD3 螺旋中的疏水性残基(Leu4255 和 Leu4259)与 CaM 的 N-叶形成分子间接触,而 CaMBD3 突变(L4255A 和 L4259A)都削弱了 CaM 与 RyR2 的结合。CaMBD3 螺旋相反侧的芳基残基(Phe4246 和 Tyr4250)与 CaM 的 C-叶相互作用,但突变体(F4246A 和 Y4250A)在溶液中对 CaM 结合没有可检测的影响。我们认为,CaM 与 CaMBD3 的结合以及第五个 Ca 与 CaM 的结合可能有助于调节 RyR2 通道功能。